Editas Medicine, Inc. (EDIT) has 165 open-market insider trades by 24 insiders since 2016. Over the last six months insiders net sold $79K. The most active filer is Katrine Bosley, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Kevin Bitterman | Dir | — | 10 | $33.2M | 2017-05-22 |
| Katrine Bosley | CEOPres | — | 22 | $7.0M | 2019-01-08 |
| Andrew A. F. Hack | CFO | — | 16 | $5.0M | 2019-02-04 |
| Charles Albright | CSOVP | — | 13 | $3.8M | 2020-12-15 |
| James C. Mullen | CEO | — | 4 | $3.6M | 2022-01-03 |
| Vickesh Myer | CTO | — | 10 | $2.3M | 2019-03-18 |
| Polaris Venture Partners Founders' Fund VI, L.P. via Kevin Bitterman | 10% Owner | — | 2 | $1.8M | 2016-11-23 |
| Deerfield Mgmt III, L.P. via James E. Flynn | 10% Owner | — | 1 | $1.6M | 2016-02-08 |
| Jessica Hopfield | Dir | — | 4 | $1.0M | 2024-05-13 |
| Neil O'Neill Gilmore | CEO | — | 11 | $958K | 2026-09-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Neil O'Neill Gilmore | CEO | Sell | $16K | 2026-09-03 |
| Linda Burkly | CSO & VP | Sell | $2K | 2026-09-03 |
| Amy Parison | CFO & VP | Sell | $1K | 2026-09-03 |
| Amy Parison | CFO & VP | Sell | $2K | 2026-08-03 |
| Linda Burkly | CSO & VP | Sell | $13K | 2026-07-28 |
| Amy Parison | CFO & VP | Sell | $1K | 2026-06-03 |
Companies that share insiders with EDIT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Neil O'Neill Gilmore | CEO | Sell | $42K | 2026-06-03 |
| Linda Burkly | CSO & VP | Sell | $2K | 2026-06-03 |
| Amy Parison | CFO & SVP | Sell | $957 | 2026-03-03 |
| Neil O'Neill Gilmore | CEO | Sell | $11K | 2026-03-03 |
| Linda Burkly | EVP & CHIEF SCIENTIFIC OFFICER | Sell | $2K | 2026-03-03 |
| Linda Burkly | EVP & CHIEF SCIENTIFIC OFFICER | Sell | $2K | 2025-12-03 |
| Neil O'Neill Gilmore | CEO | Sell | $12K | 2025-12-03 |
| Amy Parison | CFO & SVP | Sell | $991 | 2025-12-03 |
| Linda Burkly | EVP & CHIEF SCIENTIFIC OFFICER | Sell | $2K | 2025-09-03 |